We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+23.37%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$14M
Cap. Flow
-$1.47M
Cap. Flow %
-1.3%
Top 10 Hldgs %
43.47%
Holding
88
New
5
Increased
13
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
LUCD icon
Lucid Diagnostics
LUCD
+$1.23M
2
BFLY icon
Butterfly Network
BFLY
+$1.07M
3
ZETA icon
Zeta Global
ZETA
+$1.03M
4
SKYT
SkyWater Technology
SKYT
+$911K
5
DAWN
Day One Biopharmaceuticals
DAWN
+$566K

Top Sells

Rank Stock Value
1
ONDS icon
Ondas Inc
ONDS
+$2.24M
2
XGN icon
Exagen
XGN
+$1.88M
3
VCEL icon
Vericel Corp
VCEL
+$497K
4
SERA icon
Sera Prognostics
SERA
+$363K
5
LLY icon
Eli Lilly
LLY
+$320K

Sector Composition

Rank Sector Weight
1 Healthcare 57.9%
2 Technology 26.28%
3 Communication Services 7.77%
4 Industrials 4.53%
5 Consumer Staples 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMTC icon
26
NeuroOne Medical Technologies
NMTC
$14.7M
$1.3M 1.15%
244,667
-5,333
-2% -$26.1K
TELA icon
27
TELA Bio
TELA
$40.6M
$1.24M 1.1%
833,928
-41,937
-5% -$73.9K
QUIK icon
28
QuickLogic
QUIK
$260M
$1.24M 1.09%
204,956
+2,000
+1% +$11.8K
USIO icon
29
Usio Inc
USIO
$62.1M
$1.22M 1.07%
858,193
-133,500
-13% -$211K
AAPL icon
30
Apple
AAPL
$4.52T
$1.18M 1.04%
4,650
– –
PERI icon
31
Perion Network
PERI
$386M
$1.18M 1.04%
122,950
-5,725
-4% -$57.3K
ZETA icon
32
Zeta Global
ZETA
$6.05B
$1.14M 1.01%
+57,500
New +$1.03M
LUCD icon
33
Lucid Diagnostics
LUCD
$183M
$1.14M 1%
+1,127,000
New +$1.23M
CXDO icon
34
Crexendo
CXDO
$242M
$1.1M 0.97%
168,850
-1,750
-1% -$10.8K
NEO icon
35
NeoGenomics
NEO
$2.09B
$1.06M 0.93%
136,850
-31,100
-19% -$218K
ELUT icon
36
Elutia
ELUT
$38.5M
$1.01M 0.89%
1,131,499
-22,478
-2% -$41.7K
PFE icon
37
Pfizer
PFE
$145B
$994K 0.88%
39,009
-1,450
-4% -$35.8K
ATRC icon
38
AtriCure
ATRC
$1.98B
$978K 0.86%
27,750
-1,352
-5% -$46.6K
GILD icon
39
Gilead Sciences
GILD
$168B
$918K 0.81%
8,266
-67
-0.8% -$7.62K
T icon
40
AT&T
T
$160B
$800K 0.71%
28,342
-2,000
-7% -$56.8K
ANIP icon
41
ANI Pharmaceuticals
ANIP
$1.8B
$773K 0.68%
8,441
– –
OPRX icon
42
OptimizeRx
OPRX
$129M
$771K 0.68%
37,596
-1,500
-4% -$23.8K
CDXS icon
43
Codexis
CDXS
$154M
$751K 0.66%
307,700
-4,300
-1% -$11.7K
LFVN icon
44
LifeVantage
LFVN
$86.2M
$735K 0.65%
75,508
– –
MRK icon
45
Merck
MRK
$316B
$734K 0.65%
8,750
– –
HAIN icon
46
Hain Celestial
HAIN
$48.7M
$705K 0.62%
446,213
+321,000
+256% +$547K
CSTL icon
47
Castle Biosciences
CSTL
$953M
$641K 0.56%
28,145
+150
+0.5% +$3.05K
USB icon
48
US Bancorp
USB
$100B
$623K 0.55%
12,900
-150
-1% -$7.09K
DAWN
49
DELISTED
Day One Biopharmaceuticals
DAWN
$580K 0.51%
+82,250
New +$566K
VTRS icon
50
Viatris
VTRS
$20.6B
$571K 0.5%
57,695
+817
+1% +$7.95K
1
2
3 4

Similar funds

PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return
WLG
Williamson Legacy Group Carmel, Indiana $133M AUM 151.36% 1-Year Est. Return

Perkins Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Perkins Capital Management held 88 positions worth $113M, up 14% from $99.5M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Perkins Capital Management's Q3 2025 filing shows 5 new, 13 increased, 43 reduced and 5 closed positions. Its largest new stake was Lucid Diagnostics: 1,127,000 shares worth $1.14M. The largest sale was Ondas Inc, an estimated $2.24M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q3 2025 buy was Lucid Diagnostics: 1,127,000 shares worth $1.14M.
  • Perkins Capital Management added most to Butterfly Network in Q3 2025, an estimated $1.07M increase.
  • Perkins Capital Management's biggest Q3 2025 reduction was Ondas Inc, cutting an estimated $2.24M.
  • Perkins Capital Management fully exited Sera Prognostics in Q3 2025, selling an estimated $363K.
  • Perkins Capital Management's ten largest holdings make up 43% of its $113M portfolio in Q3 2025.
  • Perkins Capital Management opened 5 new positions and closed 5 in Q3 2025.
  • Perkins Capital Management's portfolio value rose 14% quarter-over-quarter to $113M.

Based on Perkins Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.